Erschienen in:
25.06.2021 | COVID-19 | Research and Reporting Methods
Zur Zeit gratis
Development of the Verbal Autopsy Instrument for COVID-19 (VAIC)
verfasst von:
Tony Rosen, MD, MPH, Monika M. Safford, MD, Madeline R. Sterling, MD, MPH, MS, Parag Goyal, MD, MSc, Melissa Patterson, MD, Christina Al Malouf, MD, Mary Ballin, GNP-BC CDE, Tessa Del Carmen, MD, Veronica M. LoFaso, MD, MS, Barrie L. Raik, MD, Ingrid Custodio, RN, Alyssa Elman, MSW, Sunday Clark, ScD, MPH, Mark S. Lachs, MD, MPH
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 11/2021
Einloggen, um Zugang zu erhalten
Abstract
Background
Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent’s caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths.
Objective
To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it.
Methods/Key Results
We used a multi-step process to design the VAIC and a protocol for its use. We developed a preliminary version of a verbal autopsy instrument specifically for COVID. We then pilot-tested this instrument by interviewing respondents about the deaths of 15 adults aged ≥65 during the initial COVID-19 surge in New York City. We modified it after the first 5 interviews. We then reviewed the VAIC and clinical information for the 15 deaths and developed a death adjudication process/algorithm to determine whether the underlying cause of death was definitely (40% of these pilot cases), probably (33%), possibly (13%), or unlikely/definitely not (13%) COVID-19-related. We noted differences between the adjudicated cause of death and a death certificate.
Conclusions
The VAIC and a death adjudication protocol using it may improve accuracy in identifying COVID-19-related deaths.